US 6579857
Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
expired A61KA61K31/70A61K45/06
Quick answer
US patent 6579857 (Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors) held by EVANSTON NORTHWESTERN HEALTHCARE RESEARCH INSTITUTE expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- EVANSTON NORTHWESTERN HEALTHCARE RESEARCH INSTITUTE
- Grant date
- Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/70, A61K45/06